The Daily Biotech Pulse: CHMP Backs AstraZeneca's Breast Cancer Therapies, Ipsen Buys Epizyme, FDA Holds For Nuvation Bio, Astellas Studies Here's a roundup of top developments in the biotech space over the last 24 hours: Benzinga · Jun 27, 2022
Why Hillstream BioPharma Shares Are Trading Higher Today? Hillstream BioPharma Inc (NASDAQ:HILS) shares are trading higher after it authorized a share repurchase program to acquire up to $1 million in common stock. As of March 31, Hillstream had approximately $11.1 million in cash and 11.4 million shares of common stock. "We have demonstrated strong execution and, as a result, have seen significant advancement… Benzinga · Jun 13, 2022